Hemophilia

Latest News

What We’re Reading: J&J Ends HIV Vaccine Trial; Deaths After Abortion Bans; Sanofi Looks to Hemophilia A Drug
What We’re Reading: J&J Ends HIV Vaccine Trial; Deaths After Abortion Bans; Sanofi Looks to Hemophilia A Drug

January 19th 2023

Johnson & Johnson (J&J) ends late-stage HIV vaccine trial; mothers in states with abortion bans are almost 3 times more likely to die before, during, and after birth; Sanofi hopes to release a drug for hemophilia A in 2023.

Top 5 Most-Read Hemophilia Articles of 2022
Top 5 Most-Read Hemophilia Articles of 2022

December 23rd 2022

Safety and Efficacy of New Hemophilia Treatments Are Most Important, Patients Report
Safety and Efficacy of New Hemophilia Treatments Are Most Important, Patients Report

December 7th 2022

Access to Genetic Testing in Europe for Hemophilia Needs Improvement, Study Says
Access to Genetic Testing in Europe for Hemophilia Needs Improvement, Study Says

November 26th 2022

Current Research and Logistical Considerations for Gene Therapy in Hemophilia
Current Research and Logistical Considerations for Gene Therapy in Hemophilia

November 25th 2022

Video Interviews

More News

© 2023 MJH Life Sciences
AJMC®
All rights reserved.